Publikationen von Mariana Juárez-Osorio

Ruhnau, J.; Grote, V.; Juárez-Osorio, M.; Bruder, D.; Mahour, R.; Rapp, E.; Rexer, T.; Reichl, U.: Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein. Frontiers in Bioengineering and Biotechnology 9, 699026 (2021)

Rudert, J.; Bälkner, M.; Juárez-Osorio, M.; Rexer, T.; Reichl, U.; Jacobsen, H.; Metzdorf, K.; Bruder, D.; Volckmar, J.: Adjuvanted SARS-CoV-2 spike protein vaccination with altered glycosylation elicits improved TH1 humoral and cellular immunity in mice. In European Journal of Immunology, 53 (2) Special Issue: SI Aufl., P376. Joint Conference of the Société Française d'Immunologie (SFI) and the Deutsche Gesellschaft für Immunologie (DGfI), Strasbourg (France), 26. September 2023. Wiley-VCH, Weinheim (2023)

Rexer, T.; Hoang Son, T.; Alcalá Orozco, E. A.; Juárez-Osorio, M.; Kleeberg, S.; Reichl, U.: Activated sugar for oligosaccharides synthesis. GlycoBioTec 2023, Berlin, Germany (2023)

Juárez-Osorio, M.; Darr, A.; Volckmar, J.; Bruder, D.; Rexer, T.; Reichl, U.: Towards full control over protein glycosylation: In-vitro glycoengineering of Influenza A virus Hemagglutinin and SARS-CoV-2 spike protein. 32^nd Joint Glycobiology Meeting, Utrecht (The Netherlands) (2022)

Juárez-Osorio, M.; Darr, A.; Volckmar, J.; Bruder, D.; Rexer, T.; Reichl, U.: Towards full control over protein glycosylation: in-vitro glycoengineering of influenza A virus hemagglutinin and SARS-CoV-2 spike protein. GlycoBioTec 2023, Berlin, Germany (2023)

Ruhnau, J.; Grote, V.; Juárez-Osorio, M.; Bruder, D.; Mahour, R.; Rapp, E.; Rexer, T.; Reichl, U.: Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein. glycoNET2021, virtually (2021)